2022 Q1 Form 10-Q Financial Statement

#000155837022007041 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $244.1M $236.9M
YoY Change 3.04% 6.89%
Cost Of Revenue $103.8M
YoY Change
Gross Profit $140.3M
YoY Change
Gross Profit Margin 57.47%
Selling, General & Admin $60.74M $57.31M
YoY Change 5.99% 9.67%
% of Gross Profit 43.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.829M $7.500M
YoY Change 4.39% 5.63%
% of Gross Profit 5.58%
Operating Expenses $60.74M $57.31M
YoY Change 5.99% 9.67%
Operating Profit $77.47M $84.23M
YoY Change -8.03% 4.25%
Interest Expense $205.0K $799.0K
YoY Change -74.34% -48.32%
% of Operating Profit 0.26% 0.95%
Other Income/Expense, Net
YoY Change
Pretax Income $77.67M $98.10M
YoY Change -20.82% 4.16%
Income Tax $19.59M $19.99M
% Of Pretax Income 25.22% 20.37%
Net Earnings $58.08M $78.11M
YoY Change -25.65% 9.42%
Net Earnings / Revenue 23.79% 32.97%
Basic Earnings Per Share $1.67 $1.70
Diluted Earnings Per Share $1.66 $1.69
COMMON SHARES
Basic Shares Outstanding 34.81M 46.08M
Diluted Shares Outstanding 34.90M 46.30M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $264.3M $262.3M
YoY Change 0.77% 75.45%
Cash & Equivalents $201.9M $225.8M
Short-Term Investments $62.40M $36.40M
Other Short-Term Assets $14.02M $14.48M
YoY Change -3.2% -1.44%
Inventory
Prepaid Expenses
Receivables $102.0M $91.79M
Other Receivables $0.00 $5.800M
Total Short-Term Assets $380.4M $374.3M
YoY Change 1.61% 50.74%
LONG-TERM ASSETS
Property, Plant & Equipment $136.7M $131.9M
YoY Change 3.6% 8.72%
Goodwill $160.8M $160.8M
YoY Change 0.0% 0.0%
Intangibles $183.1M $191.5M
YoY Change -4.4% -4.21%
Long-Term Investments
YoY Change
Other Assets $1.802M $2.133M
YoY Change -15.52% 21.61%
Total Long-Term Assets $538.0M $1.511B
YoY Change -64.39% 1.85%
TOTAL ASSETS
Total Short-Term Assets $380.4M $374.3M
Total Long-Term Assets $538.0M $1.511B
Total Assets $918.4M $1.885B
YoY Change -51.28% 8.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.64M $17.22M
YoY Change 72.07% -10.39%
Accrued Expenses $30.71M $29.50M
YoY Change 4.1% 40.83%
Deferred Revenue $12.17M $6.936M
YoY Change 75.49% -15.14%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $33.10M
YoY Change 0.0%
Total Short-Term Liabilities $132.7M $152.8M
YoY Change -13.15% 14.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $66.30M
YoY Change -100.0% -33.37%
Other Long-Term Liabilities $30.00K $107.0K
YoY Change -71.96% 872.73%
Total Long-Term Liabilities $30.00K $107.0K
YoY Change -71.96% 872.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $132.7M $152.8M
Total Long-Term Liabilities $30.00K $107.0K
Total Liabilities $211.9M $296.3M
YoY Change -28.48% 4.5%
SHAREHOLDERS EQUITY
Retained Earnings $1.913B $1.673B
YoY Change 14.37% 18.73%
Common Stock $300.4M $281.7M
YoY Change 6.64% 2.74%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.507B $365.7M
YoY Change 312.0% 55.58%
Treasury Stock Shares $20.55M $7.251M
Shareholders Equity $706.4M $1.589B
YoY Change
Total Liabilities & Shareholders Equity $918.4M $1.885B
YoY Change -51.28% 8.86%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $58.08M $78.11M
YoY Change -25.65% 9.42%
Depreciation, Depletion And Amortization $7.829M $7.500M
YoY Change 4.39% 5.63%
Cash From Operating Activities $70.26M $89.83M
YoY Change -21.78% 4.79%
INVESTING ACTIVITIES
Capital Expenditures -$6.879M -$9.000M
YoY Change -23.57% 47.54%
Acquisitions
YoY Change
Other Investing Activities -$62.83M -$25.80M
YoY Change 143.54% -700.0%
Cash From Investing Activities -$69.71M -$34.82M
YoY Change 100.22% 1754.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $399.6M $69.34M
YoY Change 476.21% 5.53%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -399.6M -74.95M
YoY Change 433.11% 1.39%
NET CHANGE
Cash From Operating Activities 70.26M 89.83M
Cash From Investing Activities -69.71M -34.82M
Cash From Financing Activities -399.6M -74.95M
Net Change In Cash -399.0M -19.94M
YoY Change 1901.04% -300.99%
FREE CASH FLOW
Cash From Operating Activities $70.26M $89.83M
Capital Expenditures -$6.879M -$9.000M
Free Cash Flow $77.14M $98.83M
YoY Change -21.95% 7.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001434588
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-34211
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
GRAND CANYON EDUCATION, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3356009
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2600 W. Camelback Road
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Phoenix
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85017
CY2022Q1 dei City Area Code
CityAreaCode
602
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
247-4400
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2022Q1 dei Trading Symbol
TradingSymbol
LOPE
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32319350
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
244133000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
236934000
CY2022Q1 lope Technology And Academic Services
TechnologyAndAcademicServices
36306000
CY2021Q1 lope Technology And Academic Services
TechnologyAndAcademicServices
32051000
CY2022Q1 lope Counseling Services And Support
CounselingServicesAndSupport
67513000
CY2021Q1 lope Counseling Services And Support
CounselingServicesAndSupport
61239000
CY2022Q1 us-gaap Marketing Expense
MarketingExpense
50851000
CY2021Q1 us-gaap Marketing Expense
MarketingExpense
47731000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9893000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9582000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2105000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2105000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
166668000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
152708000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
77465000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
84226000
CY2021Q1 lope Interest Income On Note Receivable
InterestIncomeOnNoteReceivable
14549000
CY2021Q1 us-gaap Interest Expense
InterestExpense
799000
CY2022Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
205000
CY2021Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
121000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
77670000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
98097000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19592000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19985000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
58078000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
78112000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.67
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.70
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.66
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.69
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34806000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46084000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34901000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46300000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201933000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
600941000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
62396000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102006000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70063000
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1275000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
14020000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8766000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
380355000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
681045000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136677000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136120000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
55672000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
57652000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
183114000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
185219000
CY2022Q1 us-gaap Goodwill
Goodwill
160766000
CY2021Q4 us-gaap Goodwill
Goodwill
160766000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1802000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1943000
CY2022Q1 us-gaap Assets
Assets
918386000
CY2021Q4 us-gaap Assets
Assets
1222745000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
29638000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24306000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
31986000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
32714000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30705000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27593000
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
20694000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5895000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12172000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10000
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
7514000
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
7426000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
132709000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
97944000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
27344000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
25962000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
30000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
37000
CY2022Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
51866000
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
53755000
CY2022Q1 us-gaap Liabilities
Liabilities
211949000
CY2021Q4 us-gaap Liabilities
Liabilities
177698000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53826000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53637000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33278000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37722000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
538000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
536000
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
20548000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
15915000
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1506766000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1107211000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
299858000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
296670000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-323000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1913130000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1855052000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
706437000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1045047000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
918386000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1222745000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
58078000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
78112000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-99000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-35000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-323000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-120000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
57755000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
77992000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1045047000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
57755000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
394930000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1435000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
706437000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1574329000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
77992000
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
63348000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2975000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2680000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1588678000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
58078000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
78112000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3190000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3019000
CY2022Q1 lope Depreciation And Amortization Excluding Intangible Assets
DepreciationAndAmortizationExcludingIntangibleAssets
5724000
CY2021Q1 lope Depreciation And Amortization Excluding Intangible Assets
DepreciationAndAmortizationExcludingIntangibleAssets
5426000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2105000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2105000
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1480000
CY2021Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1776000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-719000
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-65000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31943000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29601000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5312000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6166000
CY2022Q1 lope Increase Decrease In Operating Lease Liabilities Recognized In Exchange For Right Of Use Assets
IncreaseDecreaseInOperatingLeaseLiabilitiesRecognizedInExchangeForRightOfUseAssets
179000
CY2021Q1 lope Increase Decrease In Operating Lease Liabilities Recognized In Exchange For Right Of Use Assets
IncreaseDecreaseInOperatingLeaseLiabilitiesRecognizedInExchangeForRightOfUseAssets
165000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
5427000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
971000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2377000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10714000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
16074000
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
16305000
CY2022Q1 lope Increase Decrease In Contract With Customer Liability Excluding Student Deposits
IncreaseDecreaseInContractWithCustomerLiabilityExcludingStudentDeposits
12162000
CY2021Q1 lope Increase Decrease In Contract With Customer Liability Excluding Student Deposits
IncreaseDecreaseInContractWithCustomerLiabilityExcludingStudentDeposits
6936000
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6784000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
70260000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
89827000
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8911000
CY2022Q1 lope Payments To Develop Education Resources
PaymentsToDevelopEducationResources
95000
CY2021Q1 lope Payments To Develop Education Resources
PaymentsToDevelopEducationResources
90000
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
62834000
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
31337000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5519000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69713000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34819000
CY2021Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
8286000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
399555000
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
69342000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2680000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-399555000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-74948000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-399008000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19940000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
600941000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245769000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
201933000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
225829000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
895000
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
306000
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
230000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1442000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
876000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1980000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1586000
CY2022Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">1. Nature of Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Grand Canyon Education, <span style="white-space:pre-wrap;">Inc. (together with its subsidiaries, the “Company” or “GCE”) is a publicly traded education services company dedicated to serving colleges and universities. GCE has developed significant technological solutions, infrastructure and operational processes to provide services to these institutions on a large scale. GCE’s most significant university partner is Grand Canyon University (“GCU”), an Arizona non-profit corporation, a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases and certificates across </span>nine colleges both online, on ground at its campus in Phoenix, Arizona and at two<span style="white-space:pre-wrap;"> off-campus classroom and laboratory sites. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In January 2019, GCE began providing education services to numerous university partners across the United States, through our wholly owned subsidiary, Orbis Education, which we acquired, by merger on January 22, 2019 (the “Acquisition”). Since the Acquisition, GCE, together with Orbis Education, has continued to add additional university partners. In the healthcare field, we work in partnership with a growing number of top universities and healthcare networks across the country, offering healthcare-related academic programs at off-campus classroom and laboratory sites located near healthcare providers and developing high-quality, career-ready graduates who enter the workforce ready to meet the demands of the healthcare industry. In addition, we provided certain services to a university partner to assist them in expanding their online graduate programs. As of March 31, 2022, GCE provides education services to </span>27<span style="white-space:pre-wrap;"> university partners across the United States. </span></p>
CY2022Q1 lope Number Of University Service Partners
NumberOfUniversityServicePartners
27
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2022Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
141000
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3841000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Allowance for Credit Losses</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">The Company records its accounts receivable and previously had recorded its Secured Note (as defined above) receivable at the net amount expected to be collected. Our accounts receivable are derived through education services </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">provided to university partners. Our Secured Note receivable was derived through the sale of university-related assets to our most significant university partner, GCU. The Company maintains an allowance for credit losses resulting from our university partners not making payments. The Company determines the adequacy of the allowance by periodically evaluating each university partners balance, considering their financial condition and credit history, and considering current and forecasted economic conditions. In the first quarter of 2020, the Company adopted ASU 2016-13, </span><i style="font-style:italic;">Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments </i><span style="white-space:pre-wrap;">using a modified retrospective approach. This model requires consideration of a broader range of reasonable and supportable information and requires the Company to estimate expected credit losses including a measure of the expected risk of credit loss even if that risk is remote over the lifetime of the asset. Upon adoption, the Company recorded a reserve of </span>$5,000<span style="white-space:pre-wrap;"> on its long-term Secured Note receivable. The cumulative effect for the Company upon adoption of this new standard was </span>$3,832, net of taxes of $1,168<span style="white-space:pre-wrap;">. Bad debt expense is recorded as a technology and academic services expense in the consolidated income statements. In the fourth quarter of 2021, the Secured Note receivable was paid off and the credit loss reserve of </span>$5,000<span style="white-space:pre-wrap;"> was reversed. The Company will also continue to actively monitor the impact of the COVID-19 pandemic as well as other factors on expected credit losses.</span></p>
CY2021Q4 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-5000000
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company believes the credit risk related to cash equivalents and investments is limited due to its adherence to an investment policy that requires investments to have a minimum BBB rating, depending on the type of security, by one major rating agency at the time of purchase. All of the Company’s cash equivalents and investments as of March 31, 2022 and December 31, 2021 consist of investments rated BBB or higher by at least one rating agency. Additionally, the Company utilizes at least one financial institution to conduct initial and ongoing credit analysis on its investment portfolio to monitor and lower the potential impact of market risk associated with its cash equivalents and investment portfolio. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, which are primarily invested in money market funds or on deposit at high credit quality financial institutions in the U.S. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At March 31 2022 and December 31, 2021, the Company had $200,926 and $ 600,130 in excess of the FDIC insured limit. The Company is also subject to credit risk for its accounts receivable balance. Our dependence on our most significant university partner, with 87.6% and 87.4% of total service revenue for the three month periods ended March 31, 2022 and 2021, respectively, subjects us to the risk that declines in our customer’s operations would result in a sustained reduction in service revenue for the Company.</p>
CY2022Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
200926000
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
600130000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2022Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
62396000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
62817000
CY2022Q1 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
1000
CY2022Q1 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
422000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
62396000
CY2022Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
323000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
48136000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
5400000
CY2022Q1 lope Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Two
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearTwo
6835000
CY2022Q1 lope Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Three
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearThree
2025000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
62396000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34806000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46084000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
95000
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
216000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34901000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46300000
CY2022Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2396000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2435000
CY2022Q1 lope Lessee Operating Lease Lease Not Yet Commenced Commitment Amount
LesseeOperatingLeaseLeaseNotYetCommencedCommitmentAmount
14871000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y9M
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0306
CY2022Q1 lope Number Of Financing Leases
NumberOfFinancingLeases
0
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5000000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
269460000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
266446000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
132783000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
130326000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136677000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136120000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
210280000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27166000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
183114000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6836000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8931000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8440000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8128000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8012000
CY2022Q1 lope Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
26294000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
66641000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7261000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
59380000
CY2021Q4 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
500000000
CY2021Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1028000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3190000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3019000
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
798000
CY2021Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
755000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2392000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2264000

Files In Submission

Name View Source Status
0001558370-22-007041-index-headers.html Edgar Link pending
0001558370-22-007041-index.html Edgar Link pending
0001558370-22-007041.txt Edgar Link pending
0001558370-22-007041-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lope-20220331.xsd Edgar Link pending
lope-20220331x10q.htm Edgar Link pending
lope-20220331x10q_htm.xml Edgar Link completed
lope-20220331xex31d1.htm Edgar Link pending
lope-20220331xex31d2.htm Edgar Link pending
lope-20220331xex32d1.htm Edgar Link pending
lope-20220331xex32d2.htm Edgar Link pending
lope-20220331_cal.xml Edgar Link unprocessable
lope-20220331_def.xml Edgar Link unprocessable
lope-20220331_lab.xml Edgar Link unprocessable
lope-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending